vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2020-1-118-122vtio-1152Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCLINICAL REPORTSПрименение левосимендана при трансплантации легких в условиях ВА ЭКМОLevosimendan in lung transplant recipients on VA‑ECMOЖуравельС. В.ZhuravelS. V.

Журавель Сергей Владимирович.

129090, Москва, Б. Сухаревская пл., д. 3.

Zhuravel’ Sergey Vladimirovich.

3, Bolshaya Sukharevskaya sq., Moscow, 129090

zhsergey5@gmail.comАлександроваВ. Э.AleksandrovaV. E.

Москва

Moscow

УткинаИ. И.UtkinaI. I.

Москва

Moscow

КузнецоваН. К.KuznetsovaN. K.

Москва

Moscow

ТарабринЕ. А.TarabrinE. A.

Москва

Moscow

ГБУЗ «Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения города Москвы»РоссияN.V. Sklifosovsky Research Institute for Emergency Medicine, Moscow Healthcare DepartmentRussian Federation202022042020221118122Copyright © Журавель С.В., Александрова В.Э., Уткина И.И., Кузнецова Н.К., Тарабрин Е.А., 20202020Журавель С.В., Александрова В.Э., Уткина И.И., Кузнецова Н.К., Тарабрин Е.А.Zhuravel S.V., Aleksandrova V.E., Utkina I.I., Kuznetsova N.K., Tarabrin E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/1152

Одним из наиболее грозных осложнений в раннем послеоперационном периоде после трансплантации легких является развитие сердечно-сосудистой недостаточности. В то же время опыт применения левосимендана в раннем периоде после трансплантации легких в настоящее время незначителен и остается дискуссионным. Представлен клинический случай успешного применения левосимендана у пациента с правожелудочковой сердечной недостаточностью при трансплантации легких в условиях использования центральной вено-артериальной экстракорпоральной мембранной оксигенации (ВА ЭКМО).

Chronic heart failure is one of the most dreadful complications in the early postoperative period following lung transplantation. At the same time, the effect of using levosimendan in the early post-lung transplant period is currently insignificant and remains debatable. This paper presents a clinical case where levosimendan was successfully used in a patient with right ventricular heart failure during lung transplantation undergoing central venoarterial extracorporeal membrane oxygenation (VA-ECMO).

левосимендантрансплантация легкихправожелудочковая сердечная недостаточностьlevosimendanlung transplantationright ventricular heart failureReferencesHunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005; 112: 154–235.Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005; 112: 154–235.Forrest P. Anaesthesia and right ventricular failure. Anaesth Intensive Care. 2009 May; 37 (3): 370–385.Forrest P. Anaesthesia and right ventricular failure. Anaesth Intensive Care. 2009 May; 37 (3): 370–385.Carillo C, Pecoraro Y, Anile M, Mantovani S, Oliva A, D’Abramo A et al. Evaluation of Renal Function in Patients Undergoing Lung Transplantation. Transplant Proc. 2017 May; 49 (4): 699–701. doi: 10.1016/j.transproceed.2017.02.036.Carillo C, Pecoraro Y, Anile M, Mantovani S, Oliva A, D’Abramo A et al. Evaluation of Renal Function in Patients Undergoing Lung Transplantation. Transplant Proc. 2017 May; 49 (4): 699–701. doi: 10.1016/j.transproceed.2017.02.036.Sher Y, Mooney J, Dhillon G, Lee R, Maldonado JR. Delirium after lung transplantation: Association with recipient characteristics, hospital resource utilization, and mortality. Clin Transplant. 2017 May; 31 (5). doi: 10.1111/ctr.12966. Epub 2017 Apr 11.Sher Y, Mooney J, Dhillon G, Lee R, Maldonado JR. Delirium after lung transplantation: Association with recipient characteristics, hospital resource utilization, and mortality. Clin Transplant. 2017 May; 31 (5). doi: 10.1111/ctr.12966. Epub 2017 Apr 11.Cheng TZ, Choi KJ, Honeybrook AL, Zakare-Fagbamila RT, Gray AL, Snyder LD et al. Decreased Antibiotic Utilization After Sinus Surgery in Cystic Fibrosis Patients With Lung Transplantation. Am J Rhinol Allergy. 2019 July; 33 (4): 354–358. doi: 10.1177/1945892419830624.Cheng TZ, Choi KJ, Honeybrook AL, Zakare-Fagbamila RT, Gray AL, Snyder LD et al. Decreased Antibiotic Utilization After Sinus Surgery in Cystic Fibrosis Patients With Lung Transplantation. Am J Rhinol Allergy. 2019 July; 33 (4): 354–358. doi: 10.1177/1945892419830624.Missant C, Rex S, Segers P, Wouters PF. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Crit Care Med. 2007; 35: 707–715.Missant C, Rex S, Segers P, Wouters PF. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Crit Care Med. 2007; 35: 707–715.Bartolome SD, Torres F. Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantation. Heart Fail Rev. 2016; 21 (3): 347–356. doi: 10.1007/s10741-016-9562‑7.Bartolome SD, Torres F. Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantation. Heart Fail Rev. 2016; 21 (3): 347–356. doi: 10.1007/s10741-016-9562-7.Leather HA, Ver Eycken K, Segers P, Herijgers P, Vandermeersch E, Wouters PF. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs. Crit Care Med. 2003; 31: 2339– 2343.Leather HA, Ver Eycken K, Segers P, Herijgers P, Vandermeersch E, Wouters PF. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs. Crit Care Med. 2003; 31: 2339– 2343.Cavusoglu Y, Beyaztas A, Birdane A, Ata N. Levosimendan and pulmonary hypertension. J Cardiovasc Med (Hagerstown). 2010 Jul; 11 (7): 478–480. doi: 10.2459/JCM.0b013e32833a0a0b.Cavusoglu Y, Beyaztas A, Birdane A, Ata N. Levosimendan and pulmonary hypertension. J Cardiovasc Med (Hagerstown). 2010 Jul; 11 (7): 478–480. doi: 10.2459/JCM.0b013e32833a0a0b.Cavusoglu Y, Tek M, Birdane A, Ata N, Demirustu C, Gorenek B et al. Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine. Int J Cardiol. 2008; 127: e188–e191.Cavusoglu Y, Tek M, Birdane A, Ata N, Demirustu C, Gorenek B et al. Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine. Int J Cardiol. 2008; 127: e188–e191.Chanchlani R, Joseph Kim S, Kim ED, Banh T, Borges K, Vasilevska-Ristovska J et al. Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients. Nephrol Dial Transplant. 2017 Sep; 32 (9): 1579–1586. Published online 2017 Jul 27. doi: 10.1093/ndt/gfx205.Chanchlani R, Joseph Kim S, Kim ED, Banh T, Borges K, Vasilevska-Ristovska J et al. Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients. Nephrol Dial Transplant. 2017 Sep; 32 (9): 1579–1586. Published online 2017 Jul 27. doi: 10.1093/ndt/gfx205.Хубутия МШ, Тарабрин ЕА, Журавель СВ и др. Опыт применения экстракорпоральной мембранной оксигенации для обеспечения двусторонней трансплантации легких. Вестник трансплантологии и искусственных органов. 2014; 2: 66–74.Khubutiya MSh, Tarabrin EA, Zhuravel’ SV i dr. Opyt primeneniya ekstrakorporal’noy membrannoy oksigenatsii dlya obespecheniya dvustoronney transplantatsii legkikh. Vestnik transplantologii i iskusstvennykh organov. 2014; 2: 66–74.Hoeper MM, Benza RL, Corris P, de Perrot M, Fadel E, Keogh AM et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J. 2019 Jan; 53 (1): 1801906. doi: 10.1183/13993003.01906-2018.Hoeper MM, Benza RL, Corris P, de Perrot M, Fadel E, Keogh AM et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J. 2019 Jan; 53 (1): 1801906. doi: 10.1183/13993003.01906-2018.Sundberg S, Lilleberg J, Nieminen MS et al. Hemodynamic and neurohumoral effects of levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men. Am J Cardiol. 1995; 75: 1061–1066.Sundberg S, Lilleberg J, Nieminen MS et al. Hemodynamic and neurohumoral effects of levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men. Am J Cardiol. 1995; 75: 1061–1066.Leather HA, Ver Eycken K, Segers P et al. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs. Crit Care Med. 2003; 31: 2339–2343.Leather HA, Ver Eycken K, Segers P et al. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs. Crit Care Med. 2003; 31: 2339–2343.Sonntag S, Sundberg S, Lehtonen LA, Kleber FX. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. JACC. 2004; 43: 2177–2182.Sonntag S, Sundberg S, Lehtonen LA, Kleber FX. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. JACC. 2004; 43: 2177–2182.

The authors declare that there are no conflicts of interest present.